85 related articles for article (PubMed ID: 21743133)
1. Uncertain progress on the fuzzy boundaries of Alzheimer's disease: reading between the guidelines.
Whitehouse PJ; George DR
J Alzheimers Dis; 2011; 26(1):1-5. PubMed ID: 21743133
[No Abstract] [Full Text] [Related]
2. Guidelines for managing Alzheimer's disease: part I. Assessment.
Cummings JL; Frank JC; Cherry D; Kohatsu ND; Kemp B; Hewett L; Mittman B
Am Fam Physician; 2002 Jun; 65(11):2263-72. PubMed ID: 12074525
[TBL] [Abstract][Full Text] [Related]
3. [Professional guidelines for the diagnosis and management of Alzheimer's disease and related diseases, HAS (Haute Autorité de Santé) 2008].
Pasquier F
Rev Neurol (Paris); 2008; 164(8-9):753-4. PubMed ID: 18805307
[No Abstract] [Full Text] [Related]
4. [Early diagnosis of Alzheimer disease].
Touchon J; Ritchie K; Gely-Nargeot MC
Ann Med Interne (Paris); 1998 Jun; 149(4):193-201. PubMed ID: 11490546
[TBL] [Abstract][Full Text] [Related]
5. [Scales used for therapeutic trials in Alzheimer's disease].
Vercelletto M
Rev Neurol (Paris); 2002 Sep; 158(8-9):857-61. PubMed ID: 12386538
[No Abstract] [Full Text] [Related]
6. Retained neuropsychological abilities of individuals with Alzheimer's disease.
Hopper T; Bayles KA; Kim E
Semin Speech Lang; 2001 Nov; 22(4):261-73. PubMed ID: 11574903
[TBL] [Abstract][Full Text] [Related]
7. Neuropathological and neuropsychological changes in Alzheimer's disease. Relationship of biologic markers to behavioral markers.
Pirozzolo FJ; Inbody SB; Sims PA; Strittmatter WJ; Baskin D
Clin Geriatr Med; 1989 Aug; 5(3):425-40. PubMed ID: 2680026
[TBL] [Abstract][Full Text] [Related]
8. The patient's perspective: diagnosing and treating Alzheimer's disease.
Gates N
W V Med J; 2011; 107(3):70-1. PubMed ID: 21702420
[No Abstract] [Full Text] [Related]
9. Clinical diagnosis and course of Alzheimer's disease.
Morris JC; Rubin EH
Psychiatr Clin North Am; 1991 Jun; 14(2):223-36. PubMed ID: 2062717
[TBL] [Abstract][Full Text] [Related]
10. Rehearsal strategy use in Alzheimer's disease.
Souchay C; Moulin CJ; Isingrini M; Conway MA
Cogn Neuropsychol; 2008 Sep; 25(6):783-97. PubMed ID: 18728988
[TBL] [Abstract][Full Text] [Related]
11. [Neuropsychological diagnosis and therapeutic management of a patient with suspicion of Alzheimer's disease].
Calicis F; Jacquemin A; Van der Linden M; Wyns C
Acta Neurol Belg; 1989; 89(3-4):311-2. PubMed ID: 2516984
[No Abstract] [Full Text] [Related]
12. Mild cognitive impairment: transition between aging and Alzheimer's disease.
Petersen RC
Neurologia; 2000 Mar; 15(3):93-101. PubMed ID: 10846869
[TBL] [Abstract][Full Text] [Related]
13. [Neuropsychological exploration in dementia: presentation of a neuropsychologic battery in the study of Alzheimer's disease].
Gil i Saladié D; Jarne i Esparcia A; Delgado i González M; Peña i Casanova J
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(1):47-53. PubMed ID: 2330849
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
[TBL] [Abstract][Full Text] [Related]
15. [On "Proposal for the application and scoring of the clock drawing test in Alzheimer's disease"].
Royall DR; Román GC
Rev Neurol; 1999 Dec 16-31; 29(12):1348-9. PubMed ID: 10652771
[No Abstract] [Full Text] [Related]
16. [Contribution of the set-test to the diagnosis of Alzheimer's disease].
Pascual Millán LF; Martínez Quiñones JV; Modrego Pardo P; López del Val LJ; Mostacero Miguel E; Morales Asín F
Neurologia; 1991 Mar; 6(3):78-83. PubMed ID: 2054205
[TBL] [Abstract][Full Text] [Related]
17. The Swedish National Adult Reading Test (NART-SWE): a test of premorbid IQ.
Rolstad S; Nordlund A; Gustavsson MH; Eckerström C; Klang O; Hansen S; Wallin A
Scand J Psychol; 2008 Dec; 49(6):577-82. PubMed ID: 18705669
[TBL] [Abstract][Full Text] [Related]
18. Use of the Hayling task to measure inhibition of prepotent responses in normal aging and Alzheimer's disease.
Belleville S; Rouleau N; Van der Linden M
Brain Cogn; 2006 Nov; 62(2):113-9. PubMed ID: 16757076
[TBL] [Abstract][Full Text] [Related]
19. [Alzheimer's disease].
Kuhlmey J
Z Arztl Fortbild (Jena); 1989; 83(8):425-30. PubMed ID: 2660441
[No Abstract] [Full Text] [Related]
20. Neuropsychological assessment in Alzheimer's disease.
Storandt M
Exp Aging Res; 1991; 17(2):100-1. PubMed ID: 1794378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
